Real-time enrollment status for this cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:53 AM UTC
| NCT Number | NCT05948865 |
| Recruiting Status | Recruiting |
| Condition | Cancer |
| Phase | PHASE1 |
| Target Enrollment | 132 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Conjupro Biotherapeutics, Inc. |
| Last Updated on CT.gov | March 20, 2026 (Mar 20, 2026) |
As of August 28, 2026: Clinical trial NCT05948865 is currently recruiting participants. This phase1 study for cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Conjupro Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05948865 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05948865 was last updated Mar 20, 2026 (March 20, 2026). HelloStudys verifies this status automatically.